Featured Posts

Alleviate Lumbar Pain with Primary Weight TrainingAlleviate Lumbar Pain with Primary Weight Training Physical exercise might be a far better choice for lumbar pain than surgical procedures. A gentleman by the name of Mr. Dunn suffered from excruciating lumbar pain for...

Readmore

Curing Asthma The Organic WayCuring Asthma The Organic Way Considering all the fresh conclusions on different medication and organic treatments, you might question if there happens to be organic remedy for bronchial asthma. Do you...

Readmore

Signs That A Person Has OCDSigns That A Person Has OCD OCD is a persistent disease illness and if a person does not get some type of therapy for this disease the signs will generally, appear and disappear over a period of time...

Readmore

This Special Gadget Receives Thumbs Down as Lumbar Soreness RemedyThis Special Gadget Receives Thumbs Down as Lumbar... A popular, fairly questionable remedy for persistent lumbar pain has not been successful and therefore cannot be endorsed. Transcutaneous electrical sensory problems activation,...

Readmore

Vitamin D Might Reduce the Danger of Having Cancer of the ColonVitamin D Might Reduce the Danger of Having Cancer... Getting in more sunshine and consuming more dairy products might just assist you in reducing the chances of getting cancer of the colon. European scientists have discovered...

Readmore

New Medicine Benlysta Can Decrease Badness of Lupus

Posted by Admin | Posted in Health News, Lupus | Posted on 08-11-2009

0

According to recent Study, it has been observed that the patients who take Benlysta drug have got less Lupus outbursts. Among a brand new class of observational medicines which focuses on the disease procedure necessitated in Lupus crush normal treatment in a huge clinical test, researchers have observed that Benlysta has great cure for reducing lupus severity.

If the research findings are proved, then Benlysta would be 1st new cure for the lupus disease in 5 decades. Around one and a half million Americans are suffering from lupus which is a complex malady affecting the immunity system of an individual. It damages the tissues of the individual, causing mayhem in skin, joints and many important organs. Benlysta has been found to reduce the unnatural immunity signals there by making it calm and healthy.

The new research was done with eight hundred and sixty five patients on normal therapy which included steroids for testing lupus. Among the tested people, 1/3 of the people were given high dosage of Benlysta drug and 1/3 of the people were given low dosage of Benlysta and another 1/3 of the people were given a placebo.

Results of the Research

The chief of rheumatology, Sandra V. Navarra, MD at the Santo Tomas University in Manila located in Philippines stated the results of the research in the seventy third Annual Scientific meet held at the American College of Rheumatology.

lupusAfter 1 year, 58 percent of the patients who were given high dosage of Benlysta has a notable betterment in the severity of Lupus symptoms when compared with the 43 percent of the people who were on placebo. Patients who took Benlysta also suffered few disease outbursts, and some of the cases had severe outbursts as well as long duration between the outbursts. They also stated less fatigue and an improvement in the quality of their life. Earlier, the findings from the research proved that the drug was more effective at lowering the hair loss, pain and the skin rash when compared to the placebo injected people.

The doctors state that, many patients who take Benlysta were able to decrease the dosage of their steroids. One of the most crucial goals for the treatment was to free them from the usage of the steroids, since they can cause many side effects which are troublesome, like gain in weight, acne, bloating, very high blood pressure and some others, as per Joan T. Merill, MD the director of America’s Lupus Foundation.

Negative Effects of Benlysta

The generic negative effects that were observed include muscle pain, influenza, headache, infection is the upper regions of respiratory tract, infections in the urinary tracts, and were corresponding to the 3 groups of treatment. The severe infections were observed in among 6 percent of the patients in all the 3 groups.

The Benlysta drug manufacturers, GlaxoSmithKline and Human Genome Sciences Inc., funded the research. There is another large research conducted by using Benlysta drugs against the standard treatment and the results are planned to be published during the next month. If the Benlysta drug is found to be effective in that research also, the manufacturers are planning to apply for the approval from FDA for Benlysta.

Related Articles That You Like To Read

Post a comment

CommentLuv Enabled